Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer
Sakti Chakrabarti, Leslie Bucheit, Jason S. Starr, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004485-e004485
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Liquid biopsy for human cancer: cancer screening, monitoring, and treatment
Hao Wang, Yi Zhang, Hao Zhang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 21
The Role of Immunotherapy in Pancreatic Cancer
Reetu Mukherji, Dipanjan Debnath, Marion L. Hartley, et al.
Current Oncology (2022) Vol. 29, Iss. 10, pp. 6864-6892
Open Access | Times Cited: 58
Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic Experience
Tucker Coston, Aakash Desai, Hani M. Babiker, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 23
Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future
İbrahim Halil Şahin, Janie Y. Zhang, Turçin Saridogan, et al.
JCO Oncology Practice (2023) Vol. 19, Iss. 5, pp. 251-259
Open Access | Times Cited: 15
Immunotherapy of MSI Cancer: Facts and Hopes
H. Catherine Wilbur, Dung T. Le, Parul Agarwal
Clinical Cancer Research (2023) Vol. 30, Iss. 8, pp. 1438-1447
Closed Access | Times Cited: 14
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
Catherine O’Connor, Emily Harrold, David Lin, et al.
JAMA Oncology (2024)
Closed Access | Times Cited: 5
Aptamer-drug conjugates-loaded bacteria for pancreatic cancer synergistic therapy
Yu Xiao, Tao Pan, Wuren Da, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Pan-Cancer Prevalence of Microsatellite Instability-High (MSI-H) Identified by Circulating Tumor DNA and Associated Real-World Clinical Outcomes
Pashtoon Murtaza Kasi, Leslie Bucheit, Jiemin Liao, et al.
JCO Precision Oncology (2023), Iss. 7
Closed Access | Times Cited: 12
Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects
Maria Victoria García‐Ortiz, Pablo Cano-Ramírez, Marta Toledano‐Fonseca, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database
Tomoki Sakakida, Takeshi Ishikawa, Toshifumi Doi, et al.
Journal of Gastroenterology (2023) Vol. 59, Iss. 2, pp. 145-156
Closed Access | Times Cited: 12
Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers
Deepankar Mondal, Sapnita Shinde, Vibha Sinha, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 4
Rcoxnet: Deep Learning Framework for Enhanced Cancer Survival Prediction Integrating Random Walk with Restart with Mutation and Clinical Data
Debarka Sengupta, Stuti Kumari, Sakshi Gujral, et al.
(2025)
Closed Access
Cell-free DNA: plays an essential role in early diagnosis and immunotherapy of pancreatic cancer
Yi Wen, Grace Zhao, Chunhua Dai
Frontiers in Immunology (2025) Vol. 16
Open Access
Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive disease
Daria Kravchuk, Alexandra Lebedeva, Olesya Kuznetsova, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities
Sakti Chakrabarti, Mandana Kamgar, Amit Mahipal
Cancers (2022) Vol. 14, Iss. 11, pp. 2588-2588
Open Access | Times Cited: 15
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment
Αναστάσιος Γκουντάκος, Filippo Maria Martelli, Nicola Silvestris, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1454-1454
Open Access | Times Cited: 8
Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer
Neelima Vidula, Andrew Lipman, Shumei Kato, et al.
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 12
Pembrolizumab near the end of life in patients with metastatic pancreatic cancer: a multi-site consecutive series to examine survival and patient treatment burden
Michael H. Storandt, Nguyen H. Tran, Nichole Martin, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 2515-2520
Open Access | Times Cited: 6
A rare case of sporadic mismatch repair deficient pancreatic ductal adenocarcinoma that responded to ipilimumab and nivolumab combination treatment: case report
Maggie Han, Erkut Borazanci
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 1, pp. 458-462
Open Access | Times Cited: 5
Microsatellite instability in gastric cancer: molecular features and clinical implications
Ziwei Zhang, Zheng Liu, Yuan Gu, et al.
Clinical Cancer Bulletin (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Identifying Actionable Alterations in KRAS Wild-Type Pancreatic Cancer
Ahmed Elhariri, Jaydeepbhai Patel, Himil Mahadevia, et al.
Targeted Oncology (2024) Vol. 19, Iss. 5, pp. 679-689
Closed Access | Times Cited: 1
A case of MSI-high pancreatic body-tail cancer successfully treated with radical resection after pembrolizumab
Miki Ito, Toru Watanabe, Yoko Oga, et al.
Clinical Journal of Gastroenterology (2024) Vol. 18, Iss. 1, pp. 208-213
Closed Access | Times Cited: 1
Liquid biopsies and exosomal ncRNA: Transforming pancreatic cancer diagnostics and therapeutics
Ashok Kumar Balaraman, Ehssan Moglad, Muhammad Afzal, et al.
Clinica Chimica Acta (2024), pp. 120105-120105
Closed Access | Times Cited: 1
A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?
Victor Hugo Fonseca de Jesus, Mauro Daniel Spina Donadio, Angelo Borsarelli Carvalho Brito, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Immunotherapy advances in cancers with mismatch repair or proofreading deficiencies
Emily Alouani, Benoı̂t Rousseau, Thierry André, et al.
Nature Cancer (2022) Vol. 3, Iss. 12, pp. 1414-1417
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top